curaplex Epi Safe Administration and Training Kits # 8600-01100. Kit contains 2 Epi Safe Administ...
FDA Drug Recall #D-0371-2019 — Class II — November 1, 2018
Recall Summary
| Recall Number | D-0371-2019 |
| Classification | Class II — Moderate risk |
| Date Initiated | November 1, 2018 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Bound Tree Medical, LLC |
| Location | Dallas, TX |
| Product Type | Drugs |
| Quantity | 84 kits |
Product Description
curaplex Epi Safe Administration and Training Kits # 8600-01100. Kit contains 2 Epi Safe Administration Kit (8600-01101) and 1 Epi Safe Training Kit (8600-01102), Rx Only. Distributed by Sarnova HC, LLC's family of companies: Bound Tree Medical, LLC, Cardio Partners, Inc., Emergency Medical Producs, Inc. & Tri-anim Health Services, Inc. 5000 Tuttle Crossing Blvd, Dublin, OH 43016
Reason for Recall
Labeling: Incorrect or Missing Lot and/or Exp date: vials of epinephrine within kit 8600-01100 expired on December 2018, but the outer kit label has an expiration date of January 2020. In addition, device component (syringe) may lack 510(k) clearance.
Distribution Pattern
Distributed Nationwide in the USA
Lot / Code Information
Lot # ASM0018348, EXP 12-31-2018
Other Recalls from Bound Tree Medical, LLC
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0386-2019 | Class II | Curaplex Epi Kit NOT FOR IV USE, #8600-01120, E... | Nov 2, 2018 |
| D-0385-2019 | Class II | Curaplex Epi Safe Kit, 8600-01102 TRAINING ONLY... | Nov 2, 2018 |
| D-0383-2019 | Class II | curaplex Epi Safe Administration and Training K... | Nov 2, 2018 |
| D-0384-2019 | Class II | curaplex Epi Safe Kit, 8600-01101, contains:" ... | Nov 2, 2018 |
| D-0379-2019 | Class III | Curaplex Epi Safe Kit, Rx Only, contains: 1mL V... | Nov 1, 2018 |
Frequently Asked Questions
Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.